For Cancer Patients, Mutations Matter
Molecular profiling can open the door to additional, personalized treatment options for those with cancer.
video also available in:
Molecular Profiling for Cancer Patients
No two tumors are exactly alike. Even among people with the same type of cancer, the cells that make up each person's tumor have their own unique features—or mutations. These mutations can affect how—or if—the tumor will respond to various treatments.
Molecular profiling is a test your doctor can order to find out which mutations are present in the cells that make up your tumor. Molecular profiling could open the door to other treatment options, including targeted therapies, immunotherapies, and access to clinical trials.
How and When to Be Profiled
The Cholangiocarcinoma Foundation strongly urges early testing for all patients with any type of cancer.
The best time to be profiled is now, or as soon as possible, as the results can help direct your treatment.
Insurance Coverage for Molecular Profiling
Recognizing the value of molecular profiling in a variety of cancers, more and more, insurance companies are covering this testing.
Know More About Your Molecular Profiling Options
Perthera has partnered with the Cholangiocarcinoma Foundation to help guide you and your doctor through the genetic profiling process.